|
|
|
2008³â02¿ù12ÀÏ 00½Ã00ºÐ |
|
|
|
|
¾ÆÁÖÀÇ´ë ¹ÚÅÂÁØ, ÀÓÀÎ°æ ±³¼ö ³í¹® ¹Ì±¹ Àú¸í ÇмúÁö¿¡ °ÔÀç
|
|
¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ »ýÈÇб³½Ç ¹ÚÅÂÁØ ±³¼ö(ÁÂ)¿Í ÀÓÀÎ°æ ±³¼ö(¿ì)ÀÇ ³í¹®ÀÌ Áö³´Þ 14ÀÏ ¹Ì±¹ÀÇ ±ÇÀ§ ÀÖ´Â °£ Áúȯ ÇмúÁöÀÎ Hepatology¿¡ °ÔÀçµÆ´Ù.
¼¼°è ÃÖ°í ¼öÁØÀÇ Àο뵵 Áö¼ö¸¦ °¡Áö´Â Hepatology´Â ÁÖ·Î ¼¼°èÀûÀ¸·Î ¶Ù¾î³ °£ Áúȯ ¿¬±¸ ³í¹®À» ¼Ò°³ÇÏ´Â Çмú ÀâÁö´Ù.
À̹ø¿¡ °ÔÀçµÈ ¹Ú ±³¼ö¿Í ÀÓ ±³¼öÀÇ ³í¹® Á¦¸ñÀº ‘FoxM1ÀÇ È°¼ºÁ¶ÀýÀ» ÅëÇÑ TIS21ÀÇ °£¾Ï ¹ß»ý ¾ïÁ¦±âÀü ¿¬±¸(TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-FoxM1 regulation loop)’´Ù.
ÀÌ ³í¹®¿¡¼ ¹Ú ±³¼öÆÀÀº °£¾Ï¿¡¼ ‘TIS21’À̶ó´Â ¾Ï ¾ïÁ¦ À¯ÀüÀÚ°¡ ¼Ò½ÇµÇ°í, ÀÌ ¾Ï ¾ïÁ¦ À¯ÀüÀÚ¸¦ ¾Ï¼¼Æ÷¿¡ °ú¹ßÇöÄ×À» °æ¿ì ‘FoxM1’À̶ó´Â ´Ü¹éÁúÀÇ Àλêȸ¦ ¾ïÁ¦½ÃÄÑ ¾Ï Çü¼º ´É·ÂÀÌ ÇöÀúÈ÷ °¨¼ÒÇÑ´Ù´Â °ÍÀ» ¹àÇû´Ù.
ÇÑÆí À̹ø ³í¹® °ÔÀ縦 ÅëÇØ ¹Ú ±³¼ö¿Í ÀÓ ±³¼ö´Â »ý¹°Çבּ¸Á¤º¸¼¾ÅÍÀÇ È¨ÆäÀÌÁö(bric.postech.ac.kr) ‘Çѱ¹À» ºû³»´Â »ç¶÷µé’¿¡µµ ¼Ò°³µÆ´Ù.
|
|
|
|
|
|